首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Presse medicale

缩写:PRESSE MED

ISSN:0755-4982

e-ISSN:2213-0276

IF/分区:5.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3852
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jean-François Gehanno,Laetitia Rollin,Lynda Bensefa-Colas Jean-François Gehanno
Background: Infectious diseases represent a major component of biological hazards encountered by healthcare workers. Occupational exposure may occur through multiple transmission pathways including airborne particles, dir...
Christian Géraut,Laurent Géraut Christian Géraut
The risks of health impairment in laboratories can be caused by several causes: physical, biological but also chemical. Many chemicals are handled there, sometimes without sufficient precautions. About 50000 people work in french laboratori...
Gérald Bonardel,Jean-Philippe Vuillez Gérald Bonardel
Nuclear medicine is a diagnostic and therapeutic medical specialty based on the administration of radiopharmaceuticals emitting ionizing radiation (IR). In this context, healthcare professionals are exposed to low doses of radiation during ...
Jean-Luc Drapé Jean-Luc Drapé
Occupational exposure to ionizing radiation in radiology departments is a rare but important concern, given the potential long-term health effects and the regulatory framework surrounding radioprotection. This review analyzes the main risks...
Ester Moreno-Artero,Jacob Mashiah Ester Moreno-Artero
Background and objectives: Oculo-Cutaneous Albinism and Ocular Albinism are worldwide autosomal and X-linked recessive disorders, respectively, resulting from mutations in at least 21 genes that affect melanin production ...
Ester Moreno-Artero,Jacob Mashiah,Fanny Morice-Picard et al. Ester Moreno-Artero et al.
Albinism is a genetically heterogeneous group of disorders characterized by reduced or absent melanin synthesis, leading to variable hypopigmentation of the skin, hair, and eyes, and associated ocular abnormalities such as foveal hypoplasia...
Juliette Quelain,Julien Henry,Rakiba Belkhir et al. Juliette Quelain et al.
Even though immune checkpoint inhibitors (ICI) remain effective treatments for an increasing number of cancers, they are also liable to cause immune-related adverse events (irAE). Rheumatologic manifestations occur in 5-10% of patients. The...
Alberto Picca,Dimitri Psimaras Alberto Picca
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy across multiple tumor types and disease stages. By reinvigorating antitumor immune responses, these agents may also lead to the emergence of immune-related adverse events (...